The Prevention of Failure to Rescue" Using Early Warning Scoring (VitalCare)

This study has been completed.
Sponsor:
Information provided by:
Philips Healthcare
ClinicalTrials.gov Identifier:
NCT01197326
First received: September 3, 2010
Last updated: September 7, 2010
Last verified: September 2010

September 3, 2010
September 7, 2010
August 2009
May 2010   (final data collection date for primary outcome measure)
Does the use of the EWS monitor significantly decrease the mean duration of delay before activation a MET/RRT intervention and the proportion of calls where there is a >30 minute delay between the detection for MET/RRT call criteria and team activation? [ Time Frame: 6 months ] [ Designated as safety issue: Yes ]
Same as current
Complete list of historical versions of study NCT01197326 on ClinicalTrials.gov Archive Site
Do nurses feel that their current MET/RRT system is satisfactory and do they think that their current vital sign monitoring and recording system is satisfactory? [ Time Frame: 6 months ] [ Designated as safety issue: Yes ]
Same as current
Not Provided
Not Provided
 
The Prevention of Failure to Rescue" Using Early Warning Scoring
The Use of IntelliVue Patient Monitor MP5 Rel. G.1 for the Prevention of "Failure to Rescue" Using Early Warning Score

The purpose of this study is to assess if, compared with standard paper-based systems, an automated Early Warning System (EWS) resident in a spot check patient monitor, can help to identify patients in the acute care settings but outside of the intensive care unit, who may be experiencing physiological instability and who are in need of rapid clinical intervention by a Rapid Response Team (RRT)/ Medical Emergency Team (MET).

The development of such an automated system by offers a unique opportunity to assess its user-friendliness, labour-saving effect, feasibility and clinical utility. Accordingly, we plan to conduct a research program aimed at assessing this new approach toward patient monitoring.

This study will use the hospital's Standard of Care protocol for the monitoring of vital signs (including timing and vital signs collected) and a commercially available automatic spot check monitor to collect data. No investigational procedures or devices are associated with this protocol.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

We plan to observe a non-probability, convenience sample of patients which will consist primarily of acutely ill hospitalized adult patients (at least 18 years of age). We will also enroll 1-2 pediatric units to be used as pilot data, since there is less available empiric data published in the literature. Study participants will be recruited from all eligible patients during the enrollment period who are having vital signs monitoring performed as Standard of Care.

Non-random Sample of Inpatient on Medical-surgical Wards
Device: Use the MP5 EWS monitor to measure routine vital signs
All patients on the study ward receive the same care in Groups 1 and 2. The only difference is the device used to collect the vital signs. In Group 2, the MP5 EWS spot check monitor (FDA approved and CE marked) is the vital signs collection device.
  • Group 1
    Patients who triggered MET/RRT calls prior to the use of the MP5 EWS patient monitor.
    Intervention: Device: Use the MP5 EWS monitor to measure routine vital signs
  • Group 2
    Patients who triggered MET/RRT calls after the use of the MP5 EWS patient monitor.
    Intervention: Device: Use the MP5 EWS monitor to measure routine vital signs
Bellomo R, Ackerman M, Bailey M, Beale R, Clancy G, Danesh V, Hvarfner A, Jimenez E, Konrad D, Lecardo M, Pattee KS, Ritchie J, Sherman K, Tangkau P; Vital Signs to Identify, Target, and Assess Level of Care Study (VITAL Care Study) Investigators. A controlled trial of electronic automated advisory vital signs monitoring in general hospital wards. Crit Care Med. 2012 Aug;40(8):2349-61. doi: 10.1097/CCM.0b013e318255d9a0.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
100
June 2010
May 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • all patients admitted to the study units during the period of data collection

Exclusion Criteria:

  • None
Both
18 Years and older
Yes
Contact information is only displayed when the study is recruiting subjects
Australia
 
NCT01197326
BUD33108
No
Karen K. Giuliano/Principal Scientist, Philips Healthcare
Philips Healthcare
Not Provided
Not Provided
Philips Healthcare
September 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP